14.2 C
Friday, July 1, 2022

Coronavirus vaccine. Vaccinations of children 5-11 years old in the USA – research and effectiveness

Must read

- Advertisement -

The US Food and Drug Administration (FDA) has released a study of Pfizer / BioNTech’s COVID-19 vaccines for children 5-11 years of age. As reported, the preparations are very effective in preventing symptomatic infections in children and did not cause any unexpected problems. FDA experts are expected to approve the vaccine on Tuesday.

The FDA thus confirmed the reports of Pfizer, which published studies showing that the company’s vaccine against COVID-19 is 91 percent effective in preventing the symptomatic course of the disease in younger children.


Most of the study data was collected in the United States in August and September, when the delta variant became the dominant COVID-19 mutation.

FDA experts are expected to approve the vaccine on Tuesday

- Advertisement -

In their analysis, the FDA researchers concluded that in almost every case, the benefits of the vaccine in preventing hospitalization and death from COVID-19 outweigh any serious potential side effects in children.

Currently, in the United States, the vaccine is approved for use in adolescents 12 years of age and older. US Food and Drug Administration experts are expected to meet on Tuesday to decide whether to approve a vaccine for children 5-11 years old.

Vaccination with Pfizer’s preparationPAP / EPA / ROBERT GHEMENT

If the FDA allows the use of the injections, the Centers for Disease Control and Prevention (CDC) will make additional recommendations on who should get them in the first week of November. Children in this age group could therefore start vaccinating early next month, which means they will get a chance to be fully vaccinated before Christmas.

According to CNBC, 28 million children in the United States may be approved for COVID-19 vaccination for the 5-11 age group.

Main photo source: PAP / EPA / ROBERT GHEMENT

Source link

More articles

- Advertisement -

Latest article